| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9223952 | Annales de Dermatologie et de Vénéréologie | 2005 | 11 Pages |
Abstract
Demonstration of the efficacy of anti-H1 was only confirmed in a few dermatitis. Urticaria is the indication of choice. The symptomatic use of anti-H1 may be justified within the context of other dermatitis. The second rather than the first generation molecules should be preferred because of the lesser side effects and improved pharmacokinetic profile.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
C. Gaudy-Marqueste, J.-J. Grob, M.-A. Richard,